Overview
- 119 inspections across 118 sites are on record.
- 198 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-18.
At a glance
Inspections
119
Sites
118
Observations
198
Career since
Feb 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Florence Lerebours | 18 Jun 2026 | Human Drugs | View 483 → |
| Antoine Hollebecque, M.D. | 11 Jun 2026 | Human Drugs | View 483 → |
| Scilex Pharmaceuticals Inc. | 20 May 2026 | Human Drugs | View 483 → |
| Jonathan H. Hughes, M.D. | 4 May 2026 | Medical Devices & Rad Health | |
| Protagonist Therapeutics Inc | 3 Apr 2026 | Human Drugs | View 483 → |
Sites inspected
Florence LereboursSaint-Cloud, France1 insp.
Antoine Hollebecque, M.D.Villejuif, France1 insp.
Scilex Pharmaceuticals Inc.Palo Alto, United States1 insp.
Jonathan H. Hughes, M.D.Las Vegas, United States1 insp.
Protagonist Therapeutics IncNewark, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Scott N Lim3 shared
Rumany C Penn3 shared
Nympha V Florendo3 shared
Karen D Phung3 shared
Joan T Briones2 shared
Cynthia J Tsui2 shared
John A Gonzalez2 shared
Steven B Chiu2 shared
Lucila B Nwatu2 shared
Thea C Grome2 shared
Full investigator report
Get the verbatim findings behind Kristin M Abaonza's 198 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site